ArticleJournal of clinical biochemistry and nutrition2012

Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling.

Jeong-Sang Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.